Europeiska unionen - italienska - EMA (European Medicines Agency)

teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Europeiska unionen - italienska - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Europeiska unionen - italienska - EMA (European Medicines Agency)

mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Europeiska unionen - italienska - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Europeiska unionen - italienska - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

piramal critical care italia s.p.a. - dimethyl fumarate - dimethyl fumarate

Europeiska unionen - italienska - EMA (European Medicines Agency)

biogen netherlands b.v. - dimetilfumarato - sclerosi multipla - immunosoppressori - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Europeiska unionen - italienska - EMA (European Medicines Agency)

almirall s.a - dimetilfumarato - psoriasi - immunosoppressori - skilarence è indicato per il trattamento della psoriasi a placche da moderata a grave negli adulti che necessitano di terapia medicinale sistemica.

Europeiska unionen - italienska - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - sclerosi multipla recidivante-remittente - immunosoppressori - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - dimethyl fumarate - dimethyl fumarate